 Sensitivity and Specificity
"Sensitivity and Specificity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
| Descriptor ID |
D012680
|
| MeSH Number(s) |
E05.318.740.872 E05.318.780.800 G17.800 N05.715.360.750.725 N05.715.360.780.700 N06.850.520.445.800 N06.850.520.830.872
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sensitivity and Specificity".
Below are MeSH descriptors whose meaning is more specific than "Sensitivity and Specificity".
This graph shows the total number of publications written about "Sensitivity and Specificity" by people in this website by year, and whether "Sensitivity and Specificity" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 0 | 2 | 2 | | 1992 | 0 | 2 | 2 | | 1993 | 0 | 7 | 7 | | 1994 | 0 | 8 | 8 | | 1995 | 0 | 3 | 3 | | 1996 | 0 | 6 | 6 | | 1997 | 0 | 12 | 12 | | 1998 | 0 | 9 | 9 | | 1999 | 0 | 7 | 7 | | 2000 | 0 | 13 | 13 | | 2001 | 0 | 13 | 13 | | 2002 | 0 | 23 | 23 | | 2003 | 0 | 17 | 17 | | 2004 | 0 | 18 | 18 | | 2005 | 0 | 25 | 25 | | 2006 | 0 | 36 | 36 | | 2007 | 0 | 26 | 26 | | 2008 | 0 | 27 | 27 | | 2009 | 0 | 31 | 31 | | 2010 | 0 | 27 | 27 | | 2011 | 0 | 37 | 37 | | 2012 | 0 | 27 | 27 | | 2013 | 0 | 40 | 40 | | 2014 | 0 | 29 | 29 | | 2015 | 0 | 34 | 34 | | 2016 | 0 | 31 | 31 | | 2017 | 0 | 20 | 20 | | 2018 | 0 | 21 | 21 | | 2019 | 0 | 18 | 18 | | 2020 | 0 | 15 | 15 | | 2021 | 0 | 8 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Sensitivity and Specificity" by people in Profiles.
-
Fisher BT, Westling T, Boge CLK, Zaoutis TE, Dvorak CC, Nieder M, Zerr DM, Wingard JR, Villaluna D, Esbenshade AJ, Alexander S, Gunn S, Wheat LJ, Sung L. Prospective Evaluation of Galactomannan and (1?3) ß-d-Glucan Assays as Diagnostic Tools for Invasive Fungal Disease in Children, Adolescents, and Young Adults With Acute Myeloid Leukemia Receiving Fungal Prophylaxis. J Pediatric Infect Dis Soc. 2021 Sep 23; 10(8):864-871.
-
Gould MJ, Mahmud FH, Clarke ABM, McDonald C, Saibil F, Punthakee Z, Marcon MA. Accuracy of Screening Tests for Celiac Disease in Asymptomatic Patients With Type 1 Diabetes. Am J Gastroenterol. 2021 07 01; 116(7):1545-1549.
-
Kakalia S, Chakravarty A, Manson D, Lam R, Waters V, Kitai I. Choosing Wisely: Computed Tomography in the Diagnosis of Adolescents With Intrathoracic Tuberculosis. J Pediatric Infect Dis Soc. 2021 Apr 30; 10(4):521-524.
-
Limbrick DD, Morales DM, Shannon CN, Wellons JC, Kulkarni AV, Alvey JS, Reeder RW, Freimann V, Holubkov R, Riva-Cambrin JK, Whitehead WE, Rozzelle CJ, Tamber M, Oakes WJ, Drake JM, Pollack IF, Naftel RP, Inder TE, Kestle JR. Cerebrospinal fluid NCAM-1 concentration is associated with neurodevelopmental outcome in post-hemorrhagic hydrocephalus of prematurity. PLoS One. 2021; 16(3):e0247749.
-
Khanna G, Chavhan GB, Schooler GR, Fraum TJ, Alazraki AL, Squires JH, Salter A, Podberesky DJ, Towbin AJ. Diagnostic Performance of LI-RADS Version 2018 for Evaluation of Pediatric Hepatocellular Carcinoma. Radiology. 2021 04; 299(1):190-199.
-
Bohn MK, Hall A, Wilson S, Taher J, Sepiashvili L, Adeli K. Pediatric evaluation of clinical specificity and sensitivity of SARS-CoV-2 IgG and IgM serology assays. Clin Chem Lab Med. 2021 05 26; 59(6):e235-e237.
-
Raghuram K, Orlandi S, Church P, Chau T, Uleryk E, Pechlivanoglou P, Shah V. Automated movement recognition to predict motor impairment in high-risk infants: a systematic review of diagnostic test accuracy and meta-analysis. Dev Med Child Neurol. 2021 06; 63(6):637-648.
-
Lin CY, Xie J, Freedman SB, McKee RS, Schnadower D, Tarr PI, Finkelstein Y, Desai NM, Lane RD, Bergmann KR, Kaplan RL, Hariharan S, Cruz AT, Cohen DM, Dixon A, Ramgopal S, Powell EC, Kilgar J, Michelson KA, Bitzan M, Yen K, Meckler GD, Plint AC, Balamuth F, Bradin S, Gouin S, Kam AJ, Meltzer JA, Hunley TE, Avva U, Porter R, Fein DM, Louie JP, Tarr GAM. Predicting Adverse Outcomes for Shiga Toxin-Producing Escherichia coli Infections in Emergency Departments. J Pediatr. 2021 05; 232:200-206.e4.
-
Lin YC, Brooks JD, Bull SB, Gagnon F, Greenwood CMT, Hung RJ, Lawless J, Paterson AD, Sun L, Strug LJ. Statistical power in COVID-19 case-control host genomic study design. Genome Med. 2020 12 28; 12(1):115.
-
Loh TP, Lord SJ, Bell K, Bohn MK, Lim CY, Markus C, Fares Taie H, Adeli K, Lippi G, Sandberg S, Horvath A. Setting minimum clinical performance specifications for tests based on disease prevalence and minimum acceptable positive and negative predictive values: Practical considerations applied to COVID-19 testing. Clin Biochem. 2021 Feb; 88:18-22.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|